Three-dimensional imaging technology may enhance surgical selection for neoadjuvant-treated pancreatic cancer patients.

• The 3D-PANC study compares 3D-MSP imaging accuracy to conventional CT in assessing vascular involvement.
• CT has significantly low accuracy in predicting which patients benefit from surgical resection.

This could lead to improved patient outcomes by better identifying surgical candidates.

• The study will use surgical outcomes and histopathological results as the gold standard for accuracy evaluation.